Pyramid Pharma Services Adds 13th Commercial Product Through Expanded Partnership With Longstanding Customer
New cartridge-based program supports a therapy approved to treat rare blood cancers. COSTA MESA, Calif., Nov. 3, 2026 /PRNewswire/ -- Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO) specializing in sterile injectable drug products,...
Covered in this story
Call it yourself
No calls on $NOV yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on NOV →Dalsna Finance is currently tracking 140 stories mentioning NOV, the earliest published 25 Oct 2026.
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.